Delivery Order SPE2DR25D1103-SPE2DR26FE975
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,641.44 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100-strength capsules on January 7, 2026, with completion scheduled for January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order fulfills medical supply needs for federal healthcare systems, including military treatment facilities...
- The Defense Logistics Agency awarded a delivery order valued at $14,780.36 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-competitive delivery order represents a firm fixed-price transaction with performance based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,226.15 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 28, 2026, with completion targeted for January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.92 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a direct procurement of pharmaceutical supplies to support military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules valued at $2,554.80, with an ultimate completion date of December 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,916.10 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 unit capsules (100 count) on January 12, 2026, with completion scheduled for January 13, 2026. This non-competitive delivery order utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $4,292.79 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,609.64 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $31,088.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. Performance will be completed by August 20, 2025, with fulfillment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for 36,000 unit capsules of Creon DR 100s, with a ceiling value of $1,641.42 and an ultimate completion date of January 30, 2026. This is a firm fixed-price delivery order executed without set-aside designation, reflecting open and competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE975Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,013.90 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contractor will perform this delivery from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Defense Health Agency, U.S. Coast Guard, and other government healthcare systems benefit from this flexible contract vehicle as DLA Troop Support moves toward establishing its Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.